World News Insights
1-3 Minute Gist
Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
All Topics Article
Glaxo Becomes Master of Reinventing Drugs
Keywords:
Tags: Pharmaceutical, Britain,
Reinvented drugs, by combining drugs that have lost patent protection with some other ingredient to make product extensions, accounts for 27% of Glaxo's sales growth over the last 7 years. Critics point to this as a lack of innovation in its labs. Example of this is Treximet for migraines that combines older drug Imitrex with a painkiller ingredient. Glaxo has lost 28% of its share value on the London Stock Exchange.
Western pharmaceutical company growth strategies.
07/09/2007
As sales growth slows in developed countries, pricing drops, and drug development is weak, the search for new avenues for growth.
Grouped Articles
Glaxo's Garnier Is Taking the Heat
Wall Street Journal 07/09/2007
Glaxo to Weigh Results Of New Diet Pill
Wall Street Journal 10/24/2007
Prescription-Drug Sales Growth Is Expected to Slow
Wall Street Journal 11/01/2007
BusinessWeek 12/05/2007
Osteoporosis Drug Is Amgen's Hope For a Strong Future
Wall Street Journal 12/14/2007
Glaxo Becomes Master of Reinventing Drugs
Wall Street Journal 04/17/2008
Reinventing drugs, another method to boost sales used by pharmaceutical companies.
09/29/2006
By combining drugs that have lost protection with some other ingredient to make product extensions, companies like Glaxo have generated continued sales growth. Glaxo does this with Treximet for migraines.
Grouped Articles
A J&J Copycat Could Extend Old Drug's Life - WSJ.com
Wall Street Journal 09/29/2006
Glaxo Becomes Master of Reinventing Drugs
Wall Street Journal 04/17/2008
Indiaâs Supreme Court to Hear Dispute on Drug Patents
New York Times 03/06/2012
Glaxo Tries to Shake Marketing Questions on Advair
Wall Street Journal 07/06/2012
Anemia drug made billions, but at what cost? - The Washington Post
Washington Post 07/20/2012
Safety and marketing issues raised about drugs generating large sales for pharmaceutical companies.
10/25/2006
Grouped Articles
Drug Firms Curb Ties to Doctors
Wall Street Journal 12/18/2013
Medical Journal Spikes Article On Industry Ties Of Kidney Group - WSJ.com
Wall Street Journal 12/26/2006
Amgen's Star Fades Amid Safety Questions
Wall Street Journal 04/10/2007
Suit Details How J&J Pushed Sales of Procrit
Wall Street Journal 05/10/2007
BusinessWeek 05/21/2007
Sequel for Vioxx Critic: Attack on Diabetes Pill
Wall Street Journal 05/22/2007
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us
